Mouse Anti-CHIT1 Recombinant Antibody (CBT4304) (V2LY-0625-LY2260)

Lee, J. H., Lee, C. M., Kim, M. O., Park, J. W., Kamle, S., Akosman, B., ... & Lee, C. G. (2021). Kasugamycin is a novel chitinase 1 inhibitor with strong antifibrotic effects on pulmonary fibrosis. bioRxiv.

Masrori, P., De Schaepdryver, M., Floeter, M. K., De Vocht, J., Lamaire, N., D'Hondt, A., ... & Van Damme, P. (2021). Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry.

Lee, C. M., He, C. H., Park, J. W., Lee, J. H., Kamle, S., Ma, B., ... & Lee, C. G. (2019). Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3. Life science alliance, 2(3).

Logue, E. C., Neff, C. P., Mack, D. G., Martin, A. K., Fiorillo, S., Lavelle, J., ... & Fontenot, A. P. (2019). Upregulation of chitinase 1 in alveolar macrophages of HIV-infected smokers. The Journal of Immunology, 202(5), 1363-1372.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols